Show simple item record

dc.contributor.authorMwinzi, PN
dc.contributor.authorKaranja, DM
dc.contributor.authorColley, DG
dc.contributor.authorOrago, A S
dc.contributor.authorSecor, WE
dc.date.accessioned2013-10-16T09:29:18Z
dc.date.available2013-10-16T09:29:18Z
dc.date.issued2001
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/57660
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/11471107
dc.descriptionJournal Articleen
dc.description.abstractIn vitro studies suggest that CD4(+) cells with a T helper 2 (Th2) phenotype better support human immunodeficiency virus type 1 (HIV-1) replication than do cells of the Th1 phenotype. As a result, Th2-type immune responses may be substantially affected by HIV-1 coinfection. To test this hypothesis, a comparison was done of proliferation and cytokine production by peripheral blood mononuclear cells from patients with schistosomiasis who were positive or negative for HIV-1. Patients with schistosomiasis with HIV-1 coinfections had significantly lower interleukin (IL)-4 and IL-10 production than did HIV-1-negative individuals. In contrast, interferon-gamma production levels were similar between the 2 groups. Furthermore, in patients with HIV-1, a decrease in CD4(+) T cells was correlated with an increased Th1:Th2 cytokine production ratio. The effect of praziquantel treatment on proliferation and cytokine responses also differed between HIV-1 infection groups. Thus, HIV-1 infection affects immune response patterns of patients with schistosomiasisen
dc.language.isoenen
dc.publisherUniversity of Nairobien
dc.titleCellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection.en
dc.typeArticleen
local.publisherCollege of Health Scienceen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record